Physician profile

Kristen E Fisher

Pulmonary Disease · Chesterfield, MO

NPI 1316268600

$15,407.49

in general payments reported to CMS, 2019-2025

51 companies · $3,026 in 2025

The $3,026 reported for 2025 was more than what 83% of Pulmonary Disease providers received nationally (typical 2025 total: $500).

See the full distribution for Pulmonary Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$9,202.08
Education$20.20

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Glaxosmithkline, LLC. $2,476.35 2019-2025 Trelegy Ellipta, Arexvy, Nucala
Astrazeneca Pharmaceuticals LP $2,344.97 2019-2025 Tezspire, Fasenra, Airsupra
Boehringer Ingelheim Pharmaceuticals, INC. $1,319.37 2019-2025 Ofev, Spiriva Respimat, Stiolto Respimat
Regeneron Healthcare Solutions, INC. $1,240.84 2019-2025 Dupixent
Genzyme Corporation $911.86 2019-2025
United Therapeutics Corporation $760.36 2019-2025 Tyvaso, Tyvaso, Orenitram
Insmed, INC. $737.56 2021-2025 Arikayce, Brinsupri
Novartis Pharmaceuticals Corporation $480.86 2019-2025
Grifols USA, LLC $434.41 2019-2025 Prolastin-C Liquid
Electromed, INC. $388.84 2019-2025 Smartvest
Actelion Pharmaceuticals US, INC. $384.19 2019-2025 Opsumit, Uptravi
Amgen INC. $352.87 2020-2025 Tezspire
Mylan Specialty L.P. $294.10 2019-2024 Yupelri
Merck Sharp & Dohme LLC $292.44 2020-2025 Verquvo, Zerbaxa, Winrevair
Philips North America LLC $284.13 2019-2025 (8874) Incourage, Vest Therapy Und
Show all 51 companies
CompanyGeneral paymentsYearsTop products
E.R. Squibb & Sons, L.L.C. $273.91 2019-2024 Eliquis
Pfizer INC. $258.21 2019-2025
Baxter Healthcare $251.04 2022-2025 Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System
Kestra Medical Technology Services, INC. $198.49 2025 Assure Wcd
Verona Pharma, INC. $181.45 2025 Ohtuvayre
Genentech USA, INC. $172.34 2019-2024 Xolair
Janssen Pharmaceuticals, INC $171.87 2019-2024 Xarelto
Intuitive Surgical, INC. $155.26 2023-2024
Sunovion Pharmaceuticals INC. $125.41 2019
Ani Pharmaceuticals, INC. $110.25 2024-2025 Purified Cortrophin Gel
Tactile Systems Technology INC $99.36 2024-2025 Flexitouch Plus, Entre Plus, Nimbl
Viatris Specialty LLC $76.33 2025 Yupelri
Amarin Pharma, INC. $74.07 2021-2022
Boston Scientific Corporation $51.54 2019-2022
Covis Pharma Gmbh $48.77 2021-2022
Phadia US INC. $46.39 2023 Immunocap
Kowa Pharmaceuticals America, INC. $37.92 2021-2022
Harmony Biosciences LLC $36.53 2024
Edwards Lifesciences Corporation $32.40 2022
Advanced Respiratory, INC $31.28 2019
Bayer Healthcare Pharmaceuticals INC. $29.36 2019-2021
Mallinckrodt Hospital Products INC. $26.19 2025 Acthar
Takeda Pharmaceuticals U.S.A., INC. $23.56 2025 Glassia
Gilead Sciences, INC. $19.76 2021
Nabriva Therapeutics, Plc $16.80 2020
Vifor Pharma, INC. $16.53 2025 Zemaira
Sanofi Pasteur INC. $16.45 2019
Azurity Pharmaceuticals, INC. $16.00 2025 Alvesco
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $15.76 2019
Scpharmaceuticals INC. $14.17 2025
Allergan, INC. $14.06 2019
Inari Medical, INC. $13.44 2023 Ct Thrombectomy System Kit, Flowtriever Catheter, S
Teva Pharmaceuticals USA, INC. $13.39 2023
Hikma Pharmaceuticals USA $12.90 2023 Ryaltris
Merit Medical Systems INC $12.84 2023 Elation Balloon Dilator, Aero Stent and Delivery System
Fisher & Paykel Healthcare INC $10.31 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Kristen E Fisher

$15,407.49

in general payments reported 2019-2025

Years
2019-2025
Top company
Glaxosmithkline, LLC.
Context
The $3,026 reported for 2025 was more than what 83% of Pulmonary Disease providers received nationally (typical 2025 total: $500).

https://glasscript.com/doctor/1416142/kristen-e-fisher

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.